Search results
Disconnected Pancreatic Duct Syndrome (DPDS) is an important but often overlooked complication of acute necrotising pancreatitis (ANP) that occurs due to necrosis of the main pancreatic duct (PD).
- Disconnected Pancreatic Duct Syndrome: Pancreatitis of the Disconnected ...
Disconnected pancreatic duct syndrome (DPDS) is a recognized...
- Management of Disconnected Pancreatic Duct Syndrome
A disconnected pancreatic duct most commonly follows an...
- Disconnected Pancreatic Duct Syndrome: Pancreatitis of the Disconnected ...
Feb 19, 2022 · Disconnected pancreatic duct syndrome (DPDS) is a recognized complication of necrotizing pancreatitis (NP). Manifestations include recurrent peripancreatic fluid collections (R-PFC) and pancreatocutaneous fistulae (PC-Fistulae).
Sep 20, 2024 · Pancreatic duct (PD) strictures, leaks, and disconnected ducts are important morphologic consequences of inflammatory disease of the pancreas, resulting in abdominal pain, pancreatic ascites, pancreatic pleural effusion, and external pancreatic fistula.
Disconnected duct syndrome (DDS) is an adverse sequela of acute necrotizing pancreatitis in which there is disruption of the pancreatic duct leading to a failure to deliver pancreatic secretions into the duodenum.
A disconnected pancreatic duct most commonly follows an episode of severe pancreatitis and walled-off necrosis (WON). When the latter is drained percutaneously, a pancreatic fistula connected to an upstream and disconnected duct is commonly seen.
Aug 14, 2020 · The term disconnected pancreatic duct (DPD) describes an anatomical state in which the ductal continuity between viable pancreatic tissue and duodenum is interrupted. In contrast, DPDS is a clinical condition characterized by symptomatic production of pancreatic juice in an isolated pancreatic segment.
Apr 6, 2019 · This disconnected pancreatic duct syndrome (DPDS) 35 can produce a persistent pancreatic fistula, most often presenting as a peripancreatic fluid collection. Recognition of this condition is important for therapeutic decision-making ( Supplementary Figure 2 ).
